Henry Scott Robert

Director Henry Scott Robert bought 1,818 shares of NXGL at $2.75; stock up 10.3% in 30 days; 5 insiders buying within 14 days

Director Henry Scott Robert purchased 1,818 shares at $2.75 on 2024-11-20, increasing his holdings by +1.2% to 147,553 shares total. The stock has appreciated 10.3% over the past 30 days and 27.7% over 90 days, significantly outpacing the insider's cross-ticker average 30-day return of +10.1%. His same-ticker history at NXGL shows 3 of 5 prior buys delivered positive 90-day returns, indicating some pattern of successful timing in this stock. The filing reflects a cluster pattern with 5 other insiders also buying within the past 14 days. Context: NXGL remains unprofitable (full-year net income negative) despite strong annual revenue growth of +99.7%, and the current price of $3.32 is down 5.1% from its 52-week high of $3.50.

Director Henry Scott Robert bought 10,000 shares of NXGL at $2.50; stock down 13.7% in 30 days as 4 other insiders also bought in 14-day cluster.

Director Henry Scott Robert purchased 10,000 shares of NEXGEL, INC. at $2.50 on 2024-08-23, increasing his holdings by 7.4% to 145,735 shares total. The purchase occurs within a cluster pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated confidence. However, the stock has declined 13.7% over the past 30 days and is currently 15.0% below its 52-week high of $3.19, indicating headwinds since the transaction. At NXGL specifically, Robert's prior timing record is mixed—only 2 of his 5 prior buys at this ticker showed positive 90-day returns. Fundamentally, NEXGEL reported $1.4M revenue in its latest quarter but remains unprofitable with net income of $-885.0K, though it shows annual revenue growth of +99.7%, warranting investor attention to whether this growth trajectory can ultimately drive profitability.